Page last updated: 2024-08-24

capecitabine and T-Cell Lymphoma

capecitabine has been researched along with T-Cell Lymphoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cao, L; Fan, S; Hou, W; Li, J; Li, S; Liu, L; Liu, T; Shen, Z; Song, Z; Wang, H; Wang, J; Wang, Z; Yang, S; Yoshida, S; Zhang, S; Zheng, H	1

Other Studies

1 other study(ies) available for capecitabine and T-Cell Lymphoma

Article	Year
Capecitabine Can Induce T Cell Apoptosis: A Potential Immunosuppressive Agent With Anti-Cancer Effect. Frontiers in immunology, 2021, Volume: 12 Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Capecitabine; Cell Line, Tumor; Cytokines; Endoplasmic Reticulum Stress; Humans; Immunosuppressive Agents; Lymphoma, T-Cell; Male; Mice, Inbred BALB C; Mitochondria; Reactive Oxygen Species; T-Lymphocytes; Thymidine Phosphorylase	2021

Article

Year

Capecitabine Can Induce T Cell Apoptosis: A Potential Immunosuppressive Agent With Anti-Cancer Effect.

Frontiers in immunology, 2021, Volume: 12

Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Capecitabine; Cell Line, Tumor; Cytokines; Endoplasmic Reticulum Stress; Humans; Immunosuppressive Agents; Lymphoma, T-Cell; Male; Mice, Inbred BALB C; Mitochondria; Reactive Oxygen Species; T-Lymphocytes; Thymidine Phosphorylase

2021